Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Immatics | IMTX | 18. oct 2024 | 9.88 | +3.46 |
Immersion | IMMR | 18. oct 2024 | 8.48 | +0.83 |
Immix Biopharma | IMMX | 18. oct 2024 | 1.72 | +1.78 |
ImmuCell | ICCC | 18. oct 2024 | 3.69 | +1.79 |
Immuneering A | IMRX | 18. oct 2024 | 2.24 | +7.18 |
Immunic | IMUX | 18. oct 2024 | 1.59 | 0.00 |
ImmunityBio | IBRX | 18. oct 2024 | 3.55 | +3.20 |
Immunocore ADR | IMCR | 18. oct 2024 | 34.38 | +1.87 |
Immunome | IMNM | 18. oct 2024 | 12.28 | +1.57 |
ImmunoPrecise Antibodies | IPA | 18. oct 2024 | 0.54 | +0.19 |
Immunovant | IMVT | 18. oct 2024 | 29.47 | +0.72 |
Immutep ADR | IMMP | 18. oct 2024 | 1.99 | 0.00 |
Imperial Oil | IMO | 18. oct 2024 | 76.98 | -0.67 |
Imperial Petroleum | IMPP | 18. oct 2024 | 3.76 | -0.27 |
Imperial Petroleum A Pref | IMPPP | 18. oct 2024 | 25.05 | -0.40 |
Impinj | PI | 18. oct 2024 | 218.30 | -4.99 |
Imunon | IMNN | 18. oct 2024 | 0.99 | +0.69 |
IN8bio | INAB | 18. oct 2024 | 0.27 | +17.77 |
Inari Medical | NARI | 18. oct 2024 | 44.23 | +1.75 |
Incannex Healthcare ADR | IXHL | 18. oct 2024 | 2.36 | +13.46 |
Inception Growth Acquisition | IGTA | 18. oct 2024 | 11.39 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | 18. oct 2024 | 11.41 | +2.61 |
Income Opportunity Realty Investors | IOR | 18. oct 2024 | 17.00 | -0.88 |
Incyte | INCY | 18. oct 2024 | 66.39 | -0.06 |
Indaptus Therapeutics | INDP | 18. oct 2024 | 1.51 | -2.60 |
Independence Realty Trust | IRT | 18. oct 2024 | 19.95 | +1.06 |
Independent Bank | IBCP | 18. oct 2024 | 34.12 | -2.35 |
Independent Bank | INDB | 18. oct 2024 | 61.57 | -5.41 |
Independent Bank Group | IBTX | 18. oct 2024 | 60.58 | -1.46 |
India Bull 3X Direxion | INDL | 18. oct 2024 | 70.15 | +0.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.